NL-OMON41948已完成不适用
Diagnostic validity for combined FDG and PIB-PET in Alzheimer*s disease (AD) and differential<br>diagnosis; a regional and multivariate analysis - 'Dual PET' in dementia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Age from 50 - 80 yr
- •Willingness to cooperate and sign written informed consent
排除标准
- •- History of major psychiatric illness
- •- Medications which may affect outcome
- •- Cerebrovascular disease with cortical infarcts or a Fazekas- score of 2 or higher
- •- Pregnancy
- •- Mentally incompetent to understand full consequence of a written informed consent
研究者
相似试验
尚未招募
不适用
se of combined FDG-PET/CT in diagnosing infectious complications in patients treated with intensive chemotherapy and stem cell transplant recipients for haematological malignancy.NL-OMON30325niversitair Medisch Centrum Sint Radboud30
招募中
不适用
FDG-PET and cMRI for the differential diagnosis of parkinson's disease and atypical parkinson syndromsG23.2G23.1G23.9G20Multiple system atrophy, parkinsonian type [MSA-P]Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]Degenerative disease of basal ganglia, unspecifiedParkinson diseaseDRKS00016574Klinik für Neurologie und NeurophysiologieUniversitätsklinikum Freiburg314
已完成
不适用
THE CLINICAL VALUE OF COMBINED FDG PET/CT IMAGING IN RESPONSE EVALUATION AFTER RADIOCHEMOTHERAPY IN PATIENTS WITH POTENTIALLY OPERABLE LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMANL-OMON36288Vrije Universiteit Medisch Centrum50
已完成
不适用
Prospective comparison of FDG-PET and IBZM-SPECT in the differential diagnosis of parkinsonismG31.88G20G23.1G31.0G90.3Parkinson diseaseProgressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]Circumscribed brain atrophyDRKS00003613Abteilung für Nuklearmedizin95
已完成
不适用
sefulness of FDG-PET/CT examination as prediction of effect of immune checkpoint inhibitors in patients with non-small cell lung cancer : a pilot studyadvanced and recurrent non-small cell lung cancerJPRN-UMIN000031095Kansai Medical University30